Adenosine receptors participate in anabolic-androgenic steroid-induced changes on risk assessment/anxiety-like behaviors in male and female rats

Physiol Behav. 2023 Mar 15:261:114071. doi: 10.1016/j.physbeh.2022.114071. Epub 2022 Dec 28.

Abstract

Anabolic-androgenic steroids (AAS) and caffeine can induce several behavioral alterations in humans and rodents. Administration of nandrolone decanoate is known to affect defensive responses to aversive stimuli, generally decreasing inhibitory control and increasing aggressivity but whether caffeine intake influences behavioral changes induced by AAS is unknown. The present study aimed to investigate behavioral effects of caffeine (a non-selective antagonist of adenosine receptors) alone or combined with nandrolone decanoate (one of the most commonly AAS abused) in female and male Lister Hooded rats. Our results indicated that chronic administration of nandrolone decanoate (10 mg/kg, i.m., once a week for 8 weeks) decreased risk assessment/anxiety-like behaviors (in the elevated plus maze test), regardless of sex. These effects were prevented by combined caffeine intake (0.1 g/L, p.o., ad libitum). Overall, the present study heralds a key role for caffeine intake in the modulation of nandrolone decanoate-induced behavioral changes in rats, suggesting adenosine receptors as candidate targets to manage impact of AAS on brain function and behavior.

Keywords: Anabolic-androgenic steroid; Anxiety; Behavior; Caffeine; Nandrolone decanoate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anabolic Agents* / pharmacology
  • Anabolic Androgenic Steroids* / pharmacology
  • Animals
  • Anxiety / chemically induced
  • Caffeine / pharmacology
  • Female
  • Male
  • Nandrolone Decanoate* / pharmacology
  • Rats
  • Receptors, Purinergic P1* / metabolism

Substances

  • Anabolic Agents
  • Anabolic Androgenic Steroids
  • Caffeine
  • Nandrolone Decanoate
  • Receptors, Purinergic P1